Lee Soong, Son Seung-Cheol, Han Moon-Jong, Kim Woo-Jin, Kim Soo-Hyun, Kim Hye-Ran, Jeon Woo-Kyu, Park Ki-Hong, Shin Myung-Geun
Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Hwasun, Korea.
World J Gastroenterol. 2008 Jun 28;14(24):3884-90. doi: 10.3748/wjg.14.3884.
To determine intestinal permeability, the serum tumor necrosis factor (TNF)-alpha level and urine nitric oxide (NO) metabolites are altered in liver cirrhosis (LC) with or without ascites.
Fifty-three patients with LC and 26 healthy control subjects were enrolled in the study. The intestinal permeability value is expressed as the percentage of polyethylene glycol (PEG) 400 and 3350 retrieval in 8-h urine samples as determined by high performance liquid chromatography. Serum TNF-alpha concentrations and urine NO metabolites were determined using an enzyme-linked immunosorbent assay (ELISA) and Greiss reaction method, respectively.
The intestinal permeability index was significantly higher in patients with LC with ascites than in healthy control subjects or patients with LC without ascites (0.88 +/- 0.12 vs 0.52 +/- 0.05 or 0.53 +/- 0.03, P < 0.05) and correlated with urine nitrite excretion (r = 0.98). Interestingly, the serum TNF-alpha concentration was significantly higher in LC without ascites than in control subjects or in LC with ascites (198.9 +/- 55.8 pg/mL vs 40.9 +/- 12.3 pg/mL or 32.1 +/- 13.3 pg/mL, P < 0.05). Urine nitrite excretion was significantly higher in LC with ascites than in the control subjects or in LC without ascites (1170.9 +/- 28.7 micromol/L vs 903.1 +/- 55.1 micromol/L or 956.7 +/- 47.7 micromol/L, P < 0.05).
Increased intestinal macromolecular permeability and NO is probably of importance in the pathophysiology and progression of LC with ascites, but the serum TNF-alpha concentration was not related to LC with ascites.
确定伴有或不伴有腹水的肝硬化(LC)患者的肠道通透性、血清肿瘤坏死因子(TNF)-α水平及尿一氧化氮(NO)代谢产物是否发生改变。
本研究纳入了53例LC患者和26例健康对照者。肠道通透性值通过高效液相色谱法测定8小时尿液样本中聚乙二醇(PEG)400和3350的回收率来表示。血清TNF-α浓度和尿NO代谢产物分别采用酶联免疫吸附测定(ELISA)和格里斯反应法进行测定。
伴有腹水的LC患者的肠道通透性指数显著高于健康对照者或不伴有腹水的LC患者(0.88±0.12 vs 0.52±0.05或0.53±0.03,P<0.05),且与尿亚硝酸盐排泄相关(r = 0.98)。有趣的是,不伴有腹水的LC患者的血清TNF-α浓度显著高于对照者或伴有腹水的LC患者(198.9±55.8 pg/mL vs 40.9±12.3 pg/mL或32.1±13.3 pg/mL,P<0.05)。伴有腹水的LC患者的尿亚硝酸盐排泄显著高于对照者或不伴有腹水的LC患者(1170.9±28.7 μmol/L vs �03.1±55.1 μmol/L或956.7±47.7 μmol/L,P<0.05)。
肠道大分子通透性增加和NO可能在伴有腹水的LC的病理生理学和进展中起重要作用,但血清TNF-α浓度与伴有腹水的LC无关。